SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Susan G who wrote (114)2/24/2000 8:03:00 PM
From: Robert Rose  Read Replies (1) of 746
 
Thursday February 24, 7:54 pm Eastern Time

PE-Corp-Celera has no comment on stock activity

NEW YORK, Feb 24 (Reuters) - The New York Stock Exchange said Thursday PE Corp-Celera Genomic Group
(NYSE:CRA - news) has declined comment on the recent activity of its stock.

In the past two weeks, the company's share price has risen nearly 60 percent from a close on Feb. 22 of 144 to Thursday's close of 229-7/8.

NYSE said it asked the company if there are any corporate developments that explain the unusual activity.

Celera replied it is its policy not to comment on unusual market activity.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext